Omega-conotoxin MVIIA reduces neuropathic pain after spinal cord injury by inhibiting N-type voltage-dependent calcium channels on spinal dorsal horn.

"Conflict of interest The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest."

"The author(s) declare that financial support was received for the research, authorship, and/or publication of this article. This work was supported by Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (JSPS) KAKENHI (JP 22 K09090 to NO; JP19K09323 to DU; JP21K09272 to MO), Yujin Memorial Grant (Niigata University School of Medicine) to NO, Niigata Medical Association Academic Research Grant to NO, and Adaptable and Seamless Technology Transfer Program through Target-Driven R&D (A-STEP) from the Japan Science and Technology Agency (JST) (JPMJTM20DN to DU)."